Complete List of Combination of long-acting insulin (Insulin Degludec) and GLP-1 receptor agonist (Liraglutide) Medicines
Brand: TRULICITY |
Strength: 0.75 mg |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control; may also reduce the risk of major cardiovascular events in adults with type 2 diabetes and e...
Brand: TRULICITY |
Strength: 1.5 mg |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control in adults and children aged 10 years and older; may be used in combination with other antidia...
Brand: TRULICITY |
Strength: 3 mg |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control in adults; may be used in combination with other antidiabetic medications.
Adult dose: | In...
Brand: TRULICITY |
Strength: 4.5 mg |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, and to reduce the risk of major cardiovascular events in adults...
Brand: BYDUREON |
Strength: 2 mg |
Form: Powder For Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, often in conjunction with diet and exercise.
Adult dose: | 2 ...
Brand: BYDUREON |
Strength: 2 mg |
Form: Powder For Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, often in conjunction with diet and exercise.
Adult dose: | 2 ...
Brand: BYETTA |
Strength: 10 mcg |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control in conjunction with diet and exercise
Adult dose: | Initial dose: 5 mcg subcutaneously twic...
Brand: BYETTA |
Strength: 5 mcg |
Form: Solution For Injection
Class: | Glucagon-like peptide-1 (GLP-1) receptor agonist
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control in adults
Adult dose: | Initiate at 5 mcg subcutaneously twice da...
Brand: XULTOPHY |
Strength: 100 IU/ml,3.6 mg/ml |
Form: Solution For Injection
Class: | Combination of long-acting insulin (Insulin Degludec) and GLP-1 receptor agonist (Liraglutide)
Use: | Indicated for the treatment of adults with type 2 diabetes mellitus to improve glycemic...
Brand: SOLIQUA SOLOSTAR |
Strength: 100 IU/ml,33 mcg/ml |
Form: Solution for Subcutaneous Injection
Class: | Combination of long-acting insulin (Insulin Glargine) and GLP-1 receptor agonist (Lixisenatide)
Use: | Management of type 2 diabetes mellitus in adults to improve glycemic control
Adult d...
Brand: SOLIQUA SOLOSTAR |
Strength: 100 IU/ml,50 mcg/ml |
Form: Solution For Subcutaeous Injection
Class: | Combination of long-acting insulin (Insulin Glargine) and GLP-1 receptor agonist (Lixisenatide)
Use: | Indicated for the treatment of type 2 diabetes mellitus in adults to improve glycemic ...
Brand: FITURA |
Strength: 6 mg/ml |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus; weight management in obesity
Adult dose: | Initial dose of 0.6 mg subcutaneously once daily for one week, then increas...
Brand: LIRADIAB |
Strength: 6 mg/ml |
Form: Solution For Injection
Class: | Glucagon-like peptide-1 (GLP-1) receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in patients ...
Brand: SAXENDA |
Strength: 6 mg/ml |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity.
Ad...
Brand: VICTOZA |
Strength: 6 mg/ml |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus; weight management in adults with obesity or overweight with at least one weight-related comorbidity
Adult dose: | Init...
Brand: LYXUMIA |
Strength: 10 mcg |
Form: Solution For Injection
Class: | Glucagon-like peptide-1 (GLP-1) receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus in adults, to improve glycemic control in conjunction with diet and exercise....
Brand: LYXUMIA |
Strength: 20 mcg |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Lixisenetide is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glycemic control in conjunction with diet and exercise.
Adult d...
Brand: OZEMPIC |
Strength: 0.25 mg/1.5ml |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control, and for weight management in adults with obesity or overweight with at le...
Brand: OZEMPIC |
Strength: 0.5 mg/1.5ml |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in adults with obesity or overweight ...
Brand: OZEMPIC |
Strength: 1 mg/1.5ml |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in adults with obesity or overweight ...
Brand: OZEMPIC 0.25 |
Strength: 0.25 mg/dose |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in adults with obesity or overweight w...
Brand: OZEMPIC 0.5 |
Strength: 0.5 mg/dose |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults, and for weight management in adults with obesity or overweight ...
Brand: OZEMPIC 1 |
Strength: 1 mg/dose |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the management of type 2 diabetes mellitus to improve glycemic control, and for chronic weight management in adults with obesity or overweight wi...
Brand: RYBELSUS |
Strength: 14 mg |
Form: Tablets
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may be used in conjunction with diet and exercise.
Adult d...
Brand: RYBELSUS |
Strength: 3 mg |
Form: Tablets
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, as an adjunct to diet and exercise.
Adult dose: | Initial dose...
Brand: RYBELSUS |
Strength: 7 mg |
Form: Tablets
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, as an adjunct to diet and exercise.
Adult dose: | Initial dose...
Brand: Wegovy FlexTouch |
Strength: 0.25 mg/dose |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity.
Adult dose: | ...
Brand: Wegovy FlexTouch |
Strength: 0.5 mg/dose |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity
Adult dose: | I...
Brand: Wegovy FlexTouch |
Strength: 1 mg/dose |
Form: Solution For Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity.
Adult dose: | ...
Brand: Wegovy FlexTouch |
Strength: 1.7 mg/dose |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity.
Adult dose: | ...
Brand: Wegovy FlexTouch |
Strength: 2.4 mg/dose |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity.
Ad...
Brand: Mounjaro |
Strength: 10 mg/0.5ml |
Form: Pre-filled Pen
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Initial d...
Brand: Mounjaro |
Strength: 12.5 mg/0.5ml |
Form: Prefilled Pen for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Initiate ...
Brand: Mounjaro |
Strength: 15 mg/0.5ml |
Form: Pre-filled Pen
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may assist in weight management.
Adult dose: | Initiate at...
Brand: Mounjaro |
Strength: 2.5 mg/0.5ml |
Form: Pre-filled Pen
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Initiate ...
Brand: Mounjaro |
Strength: 5 mg/0.5ml |
Form: Pre-filled Pen
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Starting ...
Brand: Mounjaro |
Strength: 7.5 mg/0.5ml |
Form: Prefilled Pen for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Treatment of type 2 diabetes mellitus in adults, as an adjunct to diet and exercise to improve glycemic control
Adult dose: | Initial dose of 5 mg once weekl...
Brand: Mounjaro KwikPen |
Strength: 10 mg/0.6ml |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Initiate ...
Brand: Mounjaro KwikPen |
Strength: 12.5 mg/0.6ml |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Initial d...
Brand: Mounjaro KwikPen |
Strength: 15 mg/0.6ml |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Initiate ...
Brand: Mounjaro KwikPen |
Strength: 5 mg/0.6ml |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, as an adjunct to diet and exercise.
Adult dose: | Initial dose...
Brand: Mounjaro KwikPen |
Strength: 7.5 mg/0.6ml |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, and may also aid in weight management.
Adult dose: | Starting ...
Brand: Mounjaro Kwikpen |
Strength: 2.5 mg/0.6ml |
Form: Solution for Subcutaneous Injection
Class: | GLP-1 receptor agonist
Use: | Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control in adults, as an adjunct to diet and exercise.
Adult dose: | Initiate at ...